rifampin and Gout

rifampin has been researched along with Gout* in 2 studies

Reviews

1 review(s) available for rifampin and Gout

ArticleYear
[Toxicity of pyrazinamide in antituberculous treatments (author's transl)].
    Revue francaise des maladies respiratoires, 1980, Volume: 8, Issue:4

    Pyrazinamide, an antituberculous drug discovered in 1952, was first considered as a toxic drug. As it appeared as a bactericidal drug for the organisms inside macrophages, its usefulness has been re-appraised. In combination with other bactericidal drugs, it contributes to speed up the sterilization of tuberculous lesions. A review of the more recent clinical trials allows to assess the real toxicity of Pyrazinamide. Prescribed at a daily dosage of 30 to 35 mg/kg (1,5 to 2 g daily), it gives no major side effects.

    Topics: Chemical and Drug Induced Liver Injury; Diarrhea; Drug Eruptions; Gout; Humans; Isoniazid; Nausea; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis

1980

Other Studies

1 other study(ies) available for rifampin and Gout

ArticleYear
[Observations on the effect of PZA, EB and RFP on uric acid metabolism].
    Zhonghua jie he he hu xi xi ji bing za zhi = Chinese journal of tuberculosis and respiratory diseases, 1986, Volume: 9, Issue:4

    Topics: Adolescent; Adult; Arthritis; Drug Therapy, Combination; Ethambutol; Female; Gout; Humans; Male; Middle Aged; Pyrazinamide; Rifampin; Tuberculosis, Pulmonary; Uric Acid

1986